Related Experiment Video
Updated: Aug 5, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Apoptosis induction and cell cycle perturbation in established cell lines by peroxysomicine A1 (T-514)
F J Martinez1, G Q Zeng, A Piñeyro
1School of Medicine, Departments of Pharmacology and Toxicology and Internal Medicine, Universidad Autónoma de Nuevo León, Ave. Gonzalitos #235 Norte, Monterrey 64460, N.L., Mexico. frmartin@ccr.dsi.uanl.mx
Abstract:
Peroxysomicine A1, a novel potential anticancer compound induced cell death in established cell lines and in a primary culture of rat neonatal cardiomyocytes. Non-transformed cells are less sensitive to the compound than transformed cell lines. Fluorescent microscopy of dying cells stained with DNA-specific dyes revealed chromatin condensation and nuclear fragmentation as well as membrane blebbing characteristic of apoptosis. Flow cytometry of cells treated with peroxysomicine A1, demonstrated appearance of cells containing less than 2C DNA, that indicated degradation of nuclear DNA, another hallmark of apoptotic cell death. Z-VAD, a nonspecific caspase inhibitor, prevented DNA fragmentation but not cell death registered by permeabilization of cell outer membrane. Peroxysomicine A1 also inhibited proliferation of various cell lines. Flow cytometry analysis showed significant accumulation of dividing cells in G2/M phases of cell cycle indicating, most likely delay in G2. These results provide initial insight into the mechanisms of action of peroxysomicine A1 and suggest that peroxysomicine A1 is a potent inhibitor of cell proliferation and inducer of apoptosis and may be a useful antineoplastic chemotherapeutic agent.
Insights
Peroxysomicine A1, a novel anticancer compound, effectively induces apoptosis (programmed cell death) and inhibits proliferation in cancer cells. It shows potential as a chemotherapeutic agent.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Novel compounds are continuously sought for cancer therapy.
- Understanding mechanisms of action is crucial for drug development.
Purpose of the Study:
- To investigate the anticancer potential of Peroxysomicine A1.
- To elucidate the mechanism of cell death induced by Peroxysomicine A1.
- To assess the effect of Peroxysomicine A1 on cell proliferation.
Main Methods:
- Cell culture (established cell lines, primary rat cardiomyocytes).
- Fluorescent microscopy for apoptosis detection (chromatin condensation, nuclear fragmentation, membrane blebbing).
- Flow cytometry for DNA content analysis and cell cycle assessment.
- Caspase inhibition studies using Z-VAD.
Main Results:
- Peroxysomicine A1 induced apoptosis in transformed cell lines and cardiomyocytes.
- Apoptosis hallmarks included DNA fragmentation and membrane blebbing.
- Cell cycle analysis revealed accumulation in G2/M phase.
- Caspase inhibition partially blocked apoptosis but not overall cell death.
Conclusions:
- Peroxysomicine A1 is a potent inducer of apoptosis and inhibitor of cell proliferation.
- The compound demonstrates significant potential as an antineoplastic chemotherapeutic agent.
- Further research into Peroxysomicine A1's mechanism is warranted.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
Cellular Injury V: Apoptosis and Autophagy

